Understanding the National Drug Code (NDC)
The National Drug Code (NDC) is a unique 11-digit code assigned to each medication, including the one with the NDC 00832-1218. This code is crucial for identifying the drug, its manufacturer, and its specific formulation.
Drug Identification: Jantoven
The NDC 00832-1218 corresponds to Jantoven, a brand name for the anticoagulant medication warfarin sodium, manufactured by Upsher-Smith Laboratories, LLC[1].
Market Context
General Market Growth
The overall prescription drug market is expected to grow at a significant rate. For instance, the market is projected to grow at a Compound Annual Growth Rate (CAGR) of 9% through 2030[3].
Competitive Landscape
Jantoven, as a warfarin sodium product, operates within a competitive anticoagulant market. This market includes both generic and branded versions of warfarin, as well as other anticoagulant medications. The competition can influence pricing and market share.
Pricing Trends
Current Pricing
As of the latest available data, specific pricing details for NDC 00832-1218 are not provided in the sources. However, pricing for prescription drugs can vary based on factors such as the vendor, the quantity purchased, and the pricing type (e.g., Federal Supply Schedule (FSS))[2][3].
Price Projections
Given the general trend of prescription drug market growth, it is likely that prices for Jantoven and similar medications will be subject to inflationary pressures. However, any significant price increases would need to be balanced against regulatory and competitive constraints.
Regulatory Environment
Pricing Caps and Regulations
Bills such as the Fair Prescription Drug Prices for Americans Act aim to cap the retail list price of certain prescription drugs and biologics at the average retail list price among several developed countries. If such legislation is enacted, it could impact the pricing strategy for Jantoven and other prescription medications[5].
Manufacturer and Supply Chain
Upsher-Smith Laboratories, LLC
As the manufacturer of Jantoven, Upsher-Smith Laboratories, LLC plays a critical role in determining the drug's pricing and availability. The company's production capacity, supply chain efficiency, and pricing strategies will influence the market dynamics of Jantoven.
Demand and Usage
Clinical Demand
Warfarin sodium is a widely used anticoagulant, particularly for patients with conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. The demand for Jantoven is likely to remain stable or increase due to the ongoing need for anticoagulant therapy.
Market Analysis Tools
Data Sources
Market analysis for Jantoven would involve using data from various sources, including the FDA NDC Directory, market research reports, and pricing databases. These sources help in understanding the drug's market position, pricing trends, and competitive landscape[4].
Price Volatility
Factors Influencing Price
Prices for prescription drugs like Jantoven can be volatile due to several factors, including changes in raw material costs, manufacturing efficiencies, regulatory changes, and competitive pressures. Any significant changes in these factors could lead to price adjustments.
Consumer and Payer Impact
Patient Access and Affordability
The pricing of Jantoven directly affects patient access and affordability. Higher prices can lead to reduced adherence to treatment, while lower prices can improve patient outcomes by making the medication more accessible.
Conclusion on Pricing Projections
Given the current market trends and regulatory environment, the price of Jantoven (NDC 00832-1218) is likely to experience moderate growth, aligned with the overall prescription drug market. However, any significant price increases will be tempered by regulatory constraints and competitive pressures.
Key Takeaways
- Market Growth: The prescription drug market, including anticoagulants like Jantoven, is expected to grow at a CAGR of 9% through 2030.
- Regulatory Environment: Potential legislation like the Fair Prescription Drug Prices for Americans Act could cap prices at international averages.
- Demand: Stable or increasing demand for anticoagulant therapy supports the market for Jantoven.
- Pricing Trends: Prices are influenced by manufacturing costs, regulatory changes, and competitive pressures.
- Consumer Impact: Pricing affects patient access and adherence to treatment.
FAQs
Q: What is the NDC 00832-1218 for?
A: The NDC 00832-1218 corresponds to Jantoven, a brand name for the anticoagulant medication warfarin sodium.
Q: Who manufactures Jantoven?
A: Jantoven is manufactured by Upsher-Smith Laboratories, LLC.
Q: What are the key factors influencing the price of Jantoven?
A: The price of Jantoven is influenced by factors such as manufacturing costs, regulatory changes, competitive pressures, and market demand.
Q: How does regulatory legislation impact the pricing of Jantoven?
A: Legislation like the Fair Prescription Drug Prices for Americans Act could cap the price of Jantoven at the average retail list price among several developed countries.
Q: What is the expected market growth for prescription drugs like Jantoven?
A: The prescription drug market, including anticoagulants like Jantoven, is expected to grow at a CAGR of 9% through 2030.
Sources:
- Upsher-Smith Laboratories, LLC - List of Drugs - NDC Labeler. FindACode.
- Latest drug prices and trends for NDC 51672-1387. DrugPatentWatch.
- Latest drug prices and trends for NDC 00054-0319. DrugPatentWatch.
- Drug Name and National Drug Code (NDC) Reference Data Instructions. CMS.
- Fair Prescription Drug Prices for Americans Act. Congress.gov.
